Catalyst Biosciences Inc. (CBIO) NASDAQ
$0.24 0.01 (2.83%)
Market Cap: $9.07M
As of 06/07/23 04:30 PM EDT. Market closed.
Catalyst Biosciences Inc. (CBIO)
NASDAQ
$0.24
0.01 (2.83%)
Market Cap: $9.07M
As of 06/07/23 04:30 PM EDT. Market closed.
Catalyst is a research and clinical development biopharmaceutical company focused on addressing unmet medical needs in rare disorders of the complement and coagulation systems. Its protease engineering platform has generated two late-stage clinical programs, including MarzAA, a subcutaneously (SQ) administered next-generation engineered coagulation Factor VIIa (FVIIa) for the treatment of ... read more
Catalyst is a research and clinical development biopharmaceutical company focused on addressing unmet medical needs in rare disorders of the complement and coagulation systems. Its protease engineering platform has generated two late-stage clinical programs, including MarzAA, a subcutaneously (SQ) administered next-generation engineered coagulation Factor VIIa (FVIIa) for the treatment of episodic bleeding in subjects with rare bleeding disorders. Its complement pipeline includes a pre-clinical C3-degrader program partnered with Biogen for dry age-related macular degeneration, an improved complement factor I protease for SQ replacement therapy in patients with CFI deficiency and C4b-degraders designed to target disorders of the classical complement pathway as well as other complement programs in development. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Nassim Usman
Full Time Employees
7
CEO Compensation (Base)
$480,800
CEO Compensation (Total)
$2.44M
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Nassim Usman
Full Time Employees
7
CEO Compensation (Base)
$480,800
CEO Compensation (Total)
$2.44M
Address
260 Littlefield Ave, California, South San Francisco, 94080-6902.
PRICE CHART FOR CATALYST BIOSCIENCES INC
From:
To:
NEWS
KEY STATS
Open
$0
Previous Close
$0.23
Days Range
$0.24 - $0.25
52 week range
$0.19 - $0.65
Volume
103
Avg. Volume (30 days)
170,067
Market Cap
$9.07M
Dividend Yield
0.00%
P/E
-1.10
Shares Outstanding
37,759,825
Open
$0
Previous Close
$0.23
Days Range
$0.24 - $0.25
52 week range
$0.19 - $0.65
Volume
103
Avg. Volume (30 days)
170,067
Market Cap
$9.07M
Dividend Yield
0.00%
P/E
-1.10
Shares Outstanding
37,759,825
Open in: 
Open in:
INSIDER TRANSACTIONS FOR CATALYST BIOSCIENCES INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| USMAN NASSIM | President & CEO | Aug 09, 2022 | Buy | $0.47 | 3,250 | 1,527 | 24,541 | Aug 10, 2022, 05:19 PM |
| Miller Seline E. | SVP Finance; Interim CFO & PAO | Aug 09, 2022 | Buy | $0.47 | 3,250 | 1,527 | 6,500 | Aug 10, 2022, 05:19 PM |
| Blouse Grant E. | Chief Scientific Officer | Aug 09, 2022 | Buy | $0.47 | 3,250 | 1,527 | 9,417 | Aug 10, 2022, 05:17 PM |
| USMAN NASSIM | President & CEO | Feb 09, 2022 | Buy | $0.46 | 3,250 | 1,495 | 21,291 | Feb 16, 2022, 08:13 PM |
| Miller Seline E. | SVP Finance; Interim CFO & PAO | Feb 09, 2022 | Buy | $0.46 | 3,250 | 1,495 | 3,250 | Feb 16, 2022, 08:10 PM |
| Blouse Grant E. | Chief Scientific Officer | Feb 09, 2022 | Buy | $0.46 | 3,250 | 1,495 | 6,167 | Feb 16, 2022, 08:07 PM |
| USMAN NASSIM | President & CEO | Aug 09, 2021 | Buy | $3.62 | 867 | 3,139 | 18,041 | Aug 11, 2021, 09:15 AM |
| Levy Howard | Chief Medical Officer | Aug 09, 2021 | Buy | $3.62 | 639 | 2,313 | 639 | Aug 11, 2021, 09:14 AM |
| Blouse Grant E. | Chief Scientific Officer | Aug 09, 2021 | Buy | $3.62 | 1,163 | 4,210 | 2,917 | Aug 11, 2021, 09:13 AM |
| USMAN NASSIM | President & CEO | Apr 05, 2021 | Option Exercise | $4.63 | 5,000 | 23,150 | 17,174 | Apr 07, 2021, 10:55 AM |
| USMAN NASSIM | President & CEO | Feb 09, 2021 | Buy | $4.81 | 582 | 2,799 | 12,174 | Feb 22, 2021, 09:33 PM |
| Levy Howard | Chief Medical Officer | Feb 09, 2021 | Buy | $4.81 | 1,670 | 8,033 | 23,390 | Feb 22, 2021, 09:33 PM |
| USMAN NASSIM | President & CEO | Aug 10, 2020 | Buy | $4.81 | 582 | 2,799 | 11,592 | Aug 12, 2020, 04:12 PM |
| Levy Howard | Chief Medical Officer | Aug 10, 2020 | Buy | $4.81 | 1,768 | 8,504 | 4,268 | Aug 12, 2020, 04:11 PM |
| Levy Howard | Chief Medical Officer | Mar 16, 2020 | Buy | $4.05 | 2,500 | 10,131 | 2,500 | Mar 17, 2020, 04:23 PM |
| USMAN NASSIM | President & CEO | Mar 13, 2020 | Buy | $3.91 | 4,000 | 15,647 | 11,010 | Mar 13, 2020, 06:56 PM |
| Richard John P | Director | Mar 13, 2020 | Buy | $3.98 | 2,500 | 9,950 | 3,716 | Mar 13, 2020, 06:56 PM |
| Cai Veronica | Controller | Mar 13, 2020 | Buy | $4.11 | 2,000 | 8,220 | 7,353 | Mar 13, 2020, 06:55 PM |
| Williams Eddie | Director | Mar 04, 2020 | Buy | $5.78 | 2,000 | 11,560 | 10,839 | Mar 04, 2020, 12:00 AM |
| Ling Geoffrey M.D. | Director | Feb 25, 2020 | Buy | $6.23 | 3,000 | 18,692 | 3,000 | Feb 27, 2020, 04:06 PM |
| LAWLOR AUGUSTINE | Director | Feb 25, 2020 | Sale | $6.10 | 69,401 | 423,506 | 0 | Feb 25, 2020, 04:21 PM |
| USMAN NASSIM | President & CEO | Feb 10, 2020 | Option Exercise | $6.23 | 430 | 2,679 | 7,010 | Feb 12, 2020, 08:28 PM |
| Levy Howard | Chief Medical Officer | Feb 10, 2020 | Option Exercise | $6.23 | 1,358 | 8,460 | 1,358 | Feb 12, 2020, 08:28 PM |
| Cai Veronica | Controller | Feb 10, 2020 | Option Exercise | $6.23 | 1,678 | 10,454 | 5,353 | Feb 12, 2020, 08:27 PM |
| Payne Fletcher | Chief Financial Officer | Aug 12, 2019 | Option Exercise | $6.51 | 1,180 | 7,682 | 3,744 | Aug 12, 2019, 04:22 PM |
| USMAN NASSIM | President & CEO | Aug 12, 2019 | Option Exercise | $6.51 | 413 | 2,689 | 6,580 | Aug 12, 2019, 04:21 PM |
| Richard John P | Director | May 24, 2019 | Buy | $8.03 | 1,000 | 8,030 | 1,216 | May 28, 2019, 09:45 AM |
| USMAN NASSIM | President & CEO | May 21, 2019 | Option Exercise | $4.63 | 4,400 | 20,372 | 10,567 | May 22, 2019, 02:17 PM |
| Levy Howard | Chief Medical Officer | May 21, 2019 | Option Exercise | $4.63 | 4,400 | 20,372 | 16,094 | May 22, 2019, 12:23 PM |
| Payne Fletcher | Chief Financial Officer | Feb 11, 2019 | Option Exercise | $7.04 | 1,002 | 7,054 | 3,731 | Feb 13, 2019, 07:19 PM |
| USMAN NASSIM | President & CEO | Feb 11, 2019 | Option Exercise | $7.04 | 350 | 2,464 | 6,167 | Feb 13, 2019, 05:01 PM |
| Levy Howard | Chief Medical Officer | Feb 11, 2019 | Option Exercise | $7.04 | 2,485 | 17,494 | 11,867 | Feb 13, 2019, 05:00 PM |
| Levy Howard | Chief Medical Officer | Jan 31, 2019 | Option Exercise | $4.63 | 1,500 | 6,945 | 9,382 | Feb 04, 2019, 04:53 PM |
| Payne Fletcher | Chief Financial Officer | Feb 04, 2019 | Option Exercise | $4.63 | 1,503 | 6,959 | 3,230 | Feb 04, 2019, 04:52 PM |
| USMAN NASSIM | President & CEO | Jan 31, 2019 | Option Exercise | $4.63 | 5,729 | 26,525 | 11,041 | Feb 04, 2019, 04:51 PM |
| Levy Howard | Chief Medical Officer | Nov 26, 2018 | Option Exercise | $4.63 | 149 | 690 | 7,709 | Nov 27, 2018, 05:01 PM |
| Levy Howard | Chief Medical Officer | Nov 16, 2018 | Option Exercise | $4.63 | 173 | 801 | 7,733 | Nov 16, 2018, 05:56 PM |
| Levy Howard | Chief Medical Officer | Nov 16, 2018 | Sale | $11.00 | 173 | 1,903 | 7,560 | Nov 16, 2018, 05:56 PM |
| HILL STEPHEN A | Director | Sep 06, 2018 | Option Exercise | $10.07 | 190 | 1,913 | 1,190 | Sep 06, 2018, 09:41 PM |
| Levy Howard | Chief Medical Officer | May 03, 2018 | Option Exercise | $4.63 | 7,560 | 35,003 | 7,560 | May 04, 2018, 04:58 PM |
| USMAN NASSIM | President & CEO | Apr 04, 2018 | Option Exercise | $4.63 | 88 | 407 | 88 | Apr 06, 2018, 05:03 PM |
| Payne Fletcher | Chief Financial Officer | Mar 26, 2018 | Option Exercise | $4.63 | 59 | 273 | 59 | Mar 28, 2018, 04:11 PM |
| Flynn James E | 10% Owner | Mar 07, 2018 | Sale | $30.00 | 7,252 | 217,560 | 814,013 | Mar 21, 2018, 04:12 PM |
| Flynn James E | 10% Owner | Mar 06, 2018 | Sale | $30.87 | 14,419 | 445,099 | 322,076 | Mar 21, 2018, 04:12 PM |
| Flynn James E | 10% Owner | Mar 06, 2018 | Sale | $30.87 | 38,042 | 1,174,315 | 849,763 | Mar 21, 2018, 04:12 PM |
| Flynn James E | 10% Owner | Mar 08, 2018 | Sale | $29.15 | 2,561 | 74,664 | 308,198 | Mar 21, 2018, 04:12 PM |
| Flynn James E | 10% Owner | Mar 08, 2018 | Sale | $29.15 | 6,756 | 196,967 | 813,147 | Mar 21, 2018, 04:12 PM |
| Flynn James E | 10% Owner | Mar 07, 2018 | Sale | $30.00 | 2,748 | 82,440 | 308,526 | Mar 21, 2018, 04:12 PM |
| Flynn James E | 10% Owner | Mar 08, 2018 | Sale | $29.15 | 9,317 | 271,631 | 1,121,345 | Mar 08, 2018, 05:18 PM |
| Flynn James E | 10% Owner | Mar 07, 2018 | Sale | $30.00 | 10,000 | 300,000 | 1,122,539 | Mar 08, 2018, 05:18 PM |
| Flynn James E | 10% Owner | Mar 06, 2018 | Sale | $30.87 | 52,461 | 1,619,414 | 1,171,839 | Mar 08, 2018, 05:18 PM |
| USMAN NASSIM | President & CEO | Dec 17, 2015 | Buy | $2.00 | 4,000 | 8,000 | 78,375 | Dec 18, 2015, 05:43 PM |
| Payne Fletcher | Chief Financial Officer | Dec 17, 2015 | Buy | $2.00 | 10,000 | 20,000 | 25,032 | Dec 18, 2015, 05:42 PM |
| HILL STEPHEN A | Director | Dec 17, 2015 | Buy | $2.03 | 5,000 | 10,150 | 20,711 | Dec 18, 2015, 05:42 PM |
| HILL STEPHEN A | Director | Aug 28, 2015 | Option Exercise | $6.72 | 12,146 | 81,621 | 15,711 | Aug 31, 2015, 03:55 PM |
| BARRIS PETER J | 10% Owner | Dec 05, 2013 | Sale | $5.13 | 1,000 | 5,131 | 0 | Dec 05, 2013, 03:15 PM |
| SANDELL SCOTT D | 10% Owner | Dec 05, 2013 | Sale | $5.13 | 1,000 | 5,131 | 0 | Dec 05, 2013, 03:15 PM |
| BARRETT M JAMES | 10% Owner | Dec 03, 2013 | Option Exercise | $3.43 | 15,000 | 51,525 | 15,000 | Dec 05, 2013, 03:07 PM |
| BARRETT M JAMES | 10% Owner | Dec 05, 2013 | Sale | $5.13 | 1,000 | 5,131 | 0 | Dec 05, 2013, 03:07 PM |
| BARRETT M JAMES | 10% Owner | Dec 03, 2013 | Sale | $5.38 | 15,000 | 80,754 | 0 | Dec 05, 2013, 03:07 PM |
| BARRIS PETER J | 10% Owner | Nov 21, 2013 | Sale | $5.16 | 5,333 | 27,533 | 1,000 | Nov 22, 2013, 05:10 PM |
| BARRETT M JAMES | 10% Owner | Nov 21, 2013 | Sale | $5.16 | 5,333 | 27,533 | 1,000 | Nov 22, 2013, 05:09 PM |
| SANDELL SCOTT D | 10% Owner | Nov 21, 2013 | Sale | $5.16 | 5,333 | 27,533 | 1,000 | Nov 22, 2013, 05:08 PM |
| BARRIS PETER J | 10% Owner | Jun 03, 2013 | Option Exercise | $0.08 | 1,000 | 75 | 6,333 | Jun 04, 2013, 05:47 PM |
| SANDELL SCOTT D | 10% Owner | Jun 03, 2013 | Option Exercise | $0.08 | 1,000 | 75 | 6,333 | Jun 04, 2013, 05:47 PM |
| BARRETT M JAMES | 10% Owner | Jun 03, 2013 | Option Exercise | $0.08 | 1,000 | 75 | 6,333 | Jun 04, 2013, 05:46 PM |
| BROWN JULIA R | Director | May 10, 2013 | Buy | $5.09 | 6,000 | 30,534 | 6,000 | May 13, 2013, 04:26 PM |
| HILL STEPHEN A | President and CEO | Mar 11, 2013 | Buy | $4.38 | 10,000 | 43,781 | 20,000 | Mar 11, 2013, 04:43 PM |
| HILL STEPHEN A | President and CEO | Mar 08, 2013 | Buy | $4.48 | 10,000 | 44,796 | 10,000 | Mar 11, 2013, 04:43 PM |
| HILL STEPHEN A | President and CEO | Mar 11, 2013 | Buy | $4.38 | 10,000 | 43,781 | 20,000 | Mar 11, 2013, 04:33 PM |
| HILL STEPHEN A | President and CEO | Mar 08, 2013 | Buy | $4.48 | 10,000 | 44,796 | 10,000 | Mar 11, 2013, 04:33 PM |
| BVF PARTNERS L P/IL | 10% Owner | Nov 16, 2012 | Buy | $4.00 | 595,000 | 2,379,822 | 2,977,919 | Nov 20, 2012, 04:21 PM |
| BARRIS PETER J | 10% Owner | Nov 19, 2012 | Option Exercise | $0.08 | 3,333 | 250 | 5,333 | Nov 20, 2012, 03:51 PM |
| SANDELL SCOTT D | 10% Owner | Nov 19, 2012 | Option Exercise | $0.08 | 3,333 | 250 | 5,333 | Nov 20, 2012, 03:50 PM |
| KRAMLICH C RICHARD | 10% Owner | Nov 19, 2012 | Option Exercise | $0.08 | 3,333 | 250 | 5,333 | Nov 20, 2012, 03:50 PM |
| BVF PARTNERS L P/IL | 10% Owner | Nov 16, 2012 | Buy | $5.11 | 73,500 | 375,460 | 2,646,619 | Nov 19, 2012, 05:21 PM |
| BVF PARTNERS L P/IL | 10% Owner | Nov 14, 2012 | Buy | $4.00 | 1,216,712 | 4,866,848 | 2,599,919 | Nov 19, 2012, 05:21 PM |
| BVF PARTNERS L P/IL | 10% Owner | Nov 08, 2012 | Buy | $4.01 | 49,329 | 197,651 | 1,827,856 | Nov 09, 2012, 04:52 PM |
| BVF PARTNERS L P/IL | 10% Owner | Nov 07, 2012 | Buy | $4.08 | 23,100 | 94,276 | 1,795,927 | Nov 09, 2012, 04:52 PM |
| BVF PARTNERS L P/IL | 10% Owner | Oct 31, 2012 | Buy | $4.06 | 52,000 | 210,896 | 1,738,827 | Nov 02, 2012, 06:35 PM |
| BVF PARTNERS L P/IL | 10% Owner | Nov 02, 2012 | Buy | $4.05 | 57,600 | 233,482 | 1,781,627 | Nov 02, 2012, 06:35 PM |
| BVF PARTNERS L P/IL | 10% Owner | Nov 01, 2012 | Buy | $4.05 | 30,100 | 121,800 | 1,745,527 | Nov 02, 2012, 06:35 PM |
| BURRILL STEVEN | Director | Jul 31, 2012 | Option Exercise | $0.08 | 4,333 | 325 | 4,333 | Aug 01, 2012, 05:22 PM |
| Richard John P | Director | Jun 08, 2012 | Buy | $4.16 | 7,500 | 31,192 | 7,500 | Jun 11, 2012, 04:54 PM |
| Bencherif Merouane | SVP, Preclinical Research | May 18, 2012 | Option Exercise | $2.93 | 15,938 | 46,698 | 15,938 | May 22, 2012, 03:10 PM |
| deBethizy J Donald | President and CEO | Feb 14, 2012 | Option Exercise | $5.10 | 798 | 4,070 | 798 | Feb 16, 2012, 05:54 PM |
| Richard John P | Director | Jul 01, 2011 | Option Exercise | $9.27 | 2,500 | 23,175 | 7,833 | Jul 06, 2011, 09:20 AM |
| Richard John P | Director | Jul 01, 2011 | Sale | $21.02 | 2,500 | 52,550 | 5,333 | Jul 06, 2011, 09:20 AM |
| Musso Alan A | SVP, CFO & Treasurer | Jun 07, 2011 | Option Exercise | $5.39 | 30,875 | 166,340 | 33,674 | Jun 08, 2011, 06:31 PM |
| Musso Alan A | SVP, CFO & Treasurer | Jun 07, 2011 | Sale | $21.80 | 30,875 | 672,973 | 2,799 | Jun 08, 2011, 06:31 PM |
| BROWN JULIA R | Director | May 13, 2011 | Option Exercise | $8.70 | 9,100 | 79,170 | 9,100 | May 13, 2011, 07:34 PM |
| BROWN JULIA R | Director | May 13, 2011 | Sale | $23.38 | 9,100 | 212,782 | 0 | May 13, 2011, 07:34 PM |
| BURRILL STEVEN | Director | May 10, 2011 | Option Exercise | $9.37 | 16,948 | 158,803 | 16,948 | May 13, 2011, 07:52 AM |
| BURRILL STEVEN | Director | May 12, 2011 | Option Exercise | $7.32 | 33,052 | 241,972 | 33,052 | May 13, 2011, 07:52 AM |
| BURRILL STEVEN | Director | May 10, 2011 | Sale | $24.13 | 2,000 | 48,253 | 0 | May 13, 2011, 07:52 AM |
| BURRILL STEVEN | Director | May 10, 2011 | Sale | $24.04 | 16,948 | 407,471 | 0 | May 13, 2011, 07:52 AM |
| BURRILL STEVEN | Director | May 12, 2011 | Sale | $23.88 | 33,052 | 789,345 | 0 | May 13, 2011, 07:52 AM |
| BURRILL STEVEN | Director | May 10, 2011 | Option Exercise | $9.37 | 16,948 | 158,803 | 16,948 | May 12, 2011, 06:59 PM |
| BURRILL STEVEN | Director | May 11, 2011 | Option Exercise | $7.32 | 33,052 | 241,972 | 33,052 | May 12, 2011, 06:59 PM |
| BURRILL STEVEN | Director | May 10, 2011 | Sale | $24.04 | 16,948 | 407,471 | 0 | May 12, 2011, 06:59 PM |
| BURRILL STEVEN | Director | May 11, 2011 | Sale | $23.88 | 33,052 | 789,345 | 0 | May 12, 2011, 06:59 PM |
| BURRILL STEVEN | Director | May 10, 2011 | Sale | $24.13 | 2,000 | 48,253 | 0 | May 12, 2011, 06:59 PM |
| Richard John P | Director | Apr 01, 2011 | Option Exercise | $9.27 | 2,500 | 23,175 | 7,833 | Apr 04, 2011, 06:41 PM |
| Richard John P | Director | Apr 01, 2011 | Sale | $26.60 | 2,500 | 66,500 | 5,333 | Apr 04, 2011, 06:41 PM |
| Caldwell William S | SVP - Drug Discovery and Dev. | Mar 31, 2011 | Option Exercise | $2.93 | 2,655 | 7,779 | 10,390 | Apr 04, 2011, 06:34 PM |
| Caldwell William S | SVP - Drug Discovery and Dev. | Mar 31, 2011 | Sale | $26.37 | 2,655 | 70,012 | 7,735 | Apr 04, 2011, 06:34 PM |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | Mar 09, 2011 | Option Exercise | $5.55 | 1,500 | 8,325 | 2,659 | Mar 11, 2011, 04:41 PM |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | Mar 09, 2011 | Sale | $30.00 | 1,500 | 45,000 | 1,159 | Mar 11, 2011, 04:41 PM |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | Mar 07, 2011 | Option Exercise | $5.55 | 500 | 2,775 | 1,659 | Mar 09, 2011, 02:53 PM |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | Mar 03, 2011 | Option Exercise | $5.55 | 5,030 | 27,917 | 6,189 | Mar 09, 2011, 02:53 PM |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | Mar 07, 2011 | Sale | $30.00 | 500 | 15,001 | 1,159 | Mar 09, 2011, 02:53 PM |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | Mar 03, 2011 | Sale | $30.00 | 5,030 | 150,900 | 1,159 | Mar 09, 2011, 02:53 PM |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | Mar 01, 2011 | Option Exercise | $5.55 | 12,703 | 70,502 | 13,862 | Mar 03, 2011, 05:10 PM |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | Mar 02, 2011 | Option Exercise | $5.55 | 200 | 1,110 | 1,359 | Mar 03, 2011, 05:10 PM |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | Mar 02, 2011 | Sale | $30.00 | 200 | 6,000 | 1,159 | Mar 03, 2011, 05:10 PM |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | Mar 01, 2011 | Sale | $30.16 | 12,703 | 383,144 | 1,159 | Mar 03, 2011, 05:10 PM |
| Brennan Jeffrey P | SVP - Bus. & Commercial Dev. | Mar 01, 2011 | Option Exercise | $2.93 | 1,264 | 3,704 | 1,264 | Mar 03, 2011, 05:04 PM |
| Brennan Jeffrey P | SVP - Bus. & Commercial Dev. | Mar 01, 2011 | Sale | $30.00 | 1,264 | 37,920 | 0 | Mar 03, 2011, 05:04 PM |
| Hicks Karen A | VP Human Resources | Mar 01, 2011 | Option Exercise | $8.44 | 1,243 | 10,489 | 1,243 | Mar 03, 2011, 05:03 PM |
| Hicks Karen A | VP Human Resources | Mar 01, 2011 | Sale | $30.00 | 1,243 | 37,290 | 0 | Mar 03, 2011, 05:03 PM |
| Caldwell William S | SVP - Drug Discovery and Dev. | Feb 28, 2011 | Option Exercise | $5.55 | 15,481 | 85,920 | 23,216 | Mar 02, 2011, 06:05 PM |
| Caldwell William S | SVP - Drug Discovery and Dev. | Mar 01, 2011 | Option Exercise | $8.51 | 11,360 | 96,674 | 19,095 | Mar 02, 2011, 06:05 PM |
| Caldwell William S | SVP - Drug Discovery and Dev. | Feb 28, 2011 | Sale | $28.00 | 15,481 | 433,468 | 7,735 | Mar 02, 2011, 06:05 PM |
| Caldwell William S | SVP - Drug Discovery and Dev. | Mar 01, 2011 | Sale | $30.00 | 11,360 | 340,800 | 7,735 | Mar 02, 2011, 06:05 PM |
| Caldwell William S | SVP - Drug Discovery and Dev. | Feb 16, 2011 | Option Exercise | $1.75 | 16,655 | 29,146 | 24,390 | Feb 18, 2011, 04:42 PM |
| Caldwell William S | SVP - Drug Discovery and Dev. | Feb 16, 2011 | Sale | $26.52 | 16,655 | 441,656 | 7,735 | Feb 18, 2011, 04:42 PM |
| Richard John P | Director | Jan 18, 2011 | Option Exercise | $2.71 | 2,500 | 6,775 | 7,833 | Jan 20, 2011, 05:45 PM |
| Richard John P | Director | Jan 19, 2011 | Option Exercise | $2.71 | 5,000 | 13,550 | 10,333 | Jan 20, 2011, 05:45 PM |
| Richard John P | Director | Jan 18, 2011 | Sale | $27.38 | 2,500 | 68,440 | 5,333 | Jan 20, 2011, 05:45 PM |
| Richard John P | Director | Jan 19, 2011 | Sale | $27.11 | 5,000 | 135,542 | 5,333 | Jan 20, 2011, 05:45 PM |
| Bencherif Merouane | SVP, Preclinical Research | Jan 19, 2011 | Option Exercise | $2.75 | 30,203 | 83,069 | 30,203 | Jan 20, 2011, 05:40 PM |
| Bencherif Merouane | SVP, Preclinical Research | Jan 18, 2011 | Option Exercise | $5.55 | 22,800 | 126,540 | 22,800 | Jan 20, 2011, 05:40 PM |
| Bencherif Merouane | SVP, Preclinical Research | Jan 19, 2011 | Sale | $27.09 | 30,203 | 818,257 | 0 | Jan 20, 2011, 05:40 PM |
| Bencherif Merouane | SVP, Preclinical Research | Jan 18, 2011 | Sale | $27.17 | 22,800 | 619,476 | 0 | Jan 20, 2011, 05:40 PM |
| Hicks Karen A | VP Human Resources | Jan 14, 2011 | Option Exercise | $2.93 | 1,719 | 5,037 | 1,719 | Jan 18, 2011, 06:34 AM |
| Hicks Karen A | VP Human Resources | Jan 13, 2011 | Option Exercise | $2.93 | 3,369 | 9,871 | 3,369 | Jan 18, 2011, 06:34 AM |
| Hicks Karen A | VP Human Resources | Jan 14, 2011 | Sale | $27.50 | 1,719 | 47,273 | 0 | Jan 18, 2011, 06:34 AM |
| Hicks Karen A | VP Human Resources | Jan 13, 2011 | Sale | $27.24 | 3,369 | 91,760 | 0 | Jan 18, 2011, 06:34 AM |
| Hicks Karen A | VP Human Resources | Jan 12, 2011 | Option Exercise | $5.91 | 11,231 | 66,420 | 11,231 | Jan 13, 2011, 06:55 PM |
| Hicks Karen A | VP Human Resources | Jan 11, 2011 | Option Exercise | $6.26 | 13,825 | 86,479 | 13,825 | Jan 13, 2011, 06:55 PM |
| Hicks Karen A | VP Human Resources | Jan 11, 2011 | Sale | $27.02 | 13,825 | 373,571 | 0 | Jan 13, 2011, 06:55 PM |
| Hicks Karen A | VP Human Resources | Jan 12, 2011 | Sale | $27.18 | 11,231 | 305,298 | 0 | Jan 13, 2011, 06:55 PM |
| Musso Alan A | SVP, CFO & Treasurer | Dec 21, 2010 | Option Exercise | $5.10 | 15,535 | 79,228 | 18,334 | Dec 23, 2010, 10:11 AM |
| Musso Alan A | SVP, CFO & Treasurer | Dec 22, 2010 | Option Exercise | $5.10 | 4,881 | 24,893 | 7,680 | Dec 23, 2010, 10:11 AM |
| Musso Alan A | SVP, CFO & Treasurer | Dec 22, 2010 | Sale | $26.47 | 4,881 | 129,200 | 2,799 | Dec 23, 2010, 10:11 AM |
| Musso Alan A | SVP, CFO & Treasurer | Dec 21, 2010 | Sale | $26.61 | 15,535 | 413,386 | 2,799 | Dec 23, 2010, 10:11 AM |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | Dec 20, 2010 | Option Exercise | $1.75 | 8,882 | 15,544 | 10,035 | Dec 21, 2010, 01:46 PM |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | Dec 17, 2010 | Option Exercise | $1.75 | 2,100 | 3,675 | 3,253 | Dec 21, 2010, 01:46 PM |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | Dec 20, 2010 | Sale | $26.02 | 8,882 | 231,120 | 1,153 | Dec 21, 2010, 01:46 PM |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | Dec 17, 2010 | Sale | $26.08 | 2,100 | 54,765 | 1,153 | Dec 21, 2010, 01:46 PM |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | Dec 16, 2010 | Option Exercise | $8.51 | 2,700 | 22,977 | 3,859 | Dec 20, 2010, 11:48 AM |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | Dec 16, 2010 | Sale | $25.24 | 2,700 | 68,142 | 1,159 | Dec 20, 2010, 11:48 AM |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | Dec 16, 2010 | Option Exercise | $1.75 | 200 | 350 | 1,353 | Dec 20, 2010, 11:47 AM |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | Dec 16, 2010 | Sale | $25.15 | 200 | 5,030 | 1,153 | Dec 20, 2010, 11:47 AM |
| Caldwell William S | SVP - Drug Discovery and Dev. | Dec 13, 2010 | Option Exercise | $1.75 | 12,000 | 21,000 | 19,735 | Dec 14, 2010, 05:24 PM |
| Caldwell William S | SVP - Drug Discovery and Dev. | Dec 13, 2010 | Sale | $23.95 | 12,000 | 287,377 | 7,735 | Dec 14, 2010, 05:24 PM |
| Brennan Jeffrey P | SVP - Bus. & Commercial Dev. | Dec 13, 2010 | Option Exercise | $2.93 | 10,000 | 29,300 | 10,000 | Dec 14, 2010, 05:23 PM |
| Brennan Jeffrey P | SVP - Bus. & Commercial Dev. | Dec 13, 2010 | Sale | $23.86 | 10,000 | 238,553 | 0 | Dec 14, 2010, 05:23 PM |
| Bencherif Merouane | SVP, Preclinical Research | Dec 10, 2010 | Option Exercise | $6.00 | 32,093 | 192,535 | 32,093 | Dec 14, 2010, 05:22 PM |
| Bencherif Merouane | SVP, Preclinical Research | Dec 10, 2010 | Sale | $24.05 | 32,093 | 771,955 | 0 | Dec 14, 2010, 05:22 PM |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | Dec 08, 2010 | Option Exercise | $5.10 | 11,250 | 57,375 | 12,403 | Dec 10, 2010, 05:43 PM |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | Dec 08, 2010 | Sale | $22.68 | 11,250 | 255,150 | 1,153 | Dec 10, 2010, 05:43 PM |
| SKALETSKY MARK B | Director | Nov 17, 2010 | Option Exercise | $7.23 | 29,500 | 213,145 | 40,832 | Nov 18, 2010, 05:23 PM |
| SKALETSKY MARK B | Director | Nov 16, 2010 | Option Exercise | $2.71 | 3,000 | 8,130 | 14,332 | Nov 18, 2010, 05:23 PM |
| SKALETSKY MARK B | Director | Nov 17, 2010 | Sale | $22.00 | 29,500 | 649,000 | 11,332 | Nov 18, 2010, 05:23 PM |
| SKALETSKY MARK B | Director | Nov 16, 2010 | Sale | $21.76 | 3,000 | 65,295 | 11,332 | Nov 18, 2010, 05:23 PM |
| BLIXT CHARLES A | Director | Nov 16, 2010 | Option Exercise | $7.56 | 9,500 | 71,790 | 9,500 | Nov 18, 2010, 05:14 PM |
| BLIXT CHARLES A | Director | Nov 17, 2010 | Option Exercise | $9.27 | 5,500 | 50,985 | 5,500 | Nov 18, 2010, 05:14 PM |
| BLIXT CHARLES A | Director | Nov 16, 2010 | Sale | $21.80 | 9,500 | 207,067 | 0 | Nov 18, 2010, 05:14 PM |
| BLIXT CHARLES A | Director | Nov 17, 2010 | Sale | $21.76 | 5,500 | 119,666 | 0 | Nov 18, 2010, 05:14 PM |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | Nov 05, 2010 | Option Exercise | $1.75 | 700 | 1,225 | 1,853 | Nov 09, 2010, 06:43 PM |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | Nov 05, 2010 | Sale | $25.02 | 700 | 17,512 | 1,153 | Nov 09, 2010, 06:43 PM |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | Nov 05, 2010 | Option Exercise | $8.51 | 1,400 | 11,914 | 2,559 | Nov 09, 2010, 06:39 PM |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | Nov 05, 2010 | Sale | $25.01 | 1,400 | 35,014 | 1,159 | Nov 09, 2010, 06:39 PM |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | Nov 04, 2010 | Option Exercise | $1.75 | 7,784 | 13,622 | 8,937 | Nov 05, 2010, 11:27 AM |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | Nov 03, 2010 | Option Exercise | $1.75 | 986 | 1,726 | 2,139 | Nov 05, 2010, 11:27 AM |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | Nov 03, 2010 | Sale | $25.05 | 986 | 24,699 | 1,153 | Nov 05, 2010, 11:27 AM |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | Nov 04, 2010 | Sale | $25.07 | 7,784 | 195,139 | 1,153 | Nov 05, 2010, 11:27 AM |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | Nov 03, 2010 | Option Exercise | $8.51 | 1,000 | 8,510 | 2,159 | Nov 05, 2010, 11:25 AM |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | Nov 04, 2010 | Option Exercise | $8.51 | 7,800 | 66,378 | 8,959 | Nov 05, 2010, 11:25 AM |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | Nov 04, 2010 | Sale | $25.08 | 7,800 | 195,605 | 1,159 | Nov 05, 2010, 11:25 AM |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | Nov 03, 2010 | Sale | $25.06 | 1,000 | 25,055 | 1,159 | Nov 05, 2010, 11:25 AM |
| Musso Alan A | SVP, CFO & Treasurer | Oct 28, 2010 | Option Exercise | $2.93 | 1,500 | 4,395 | 4,299 | Oct 28, 2010, 05:32 PM |
| Musso Alan A | SVP, CFO & Treasurer | Oct 26, 2010 | Option Exercise | $2.93 | 2,000 | 5,860 | 4,799 | Oct 28, 2010, 05:32 PM |
| Musso Alan A | SVP, CFO & Treasurer | Oct 28, 2010 | Sale | $24.60 | 1,500 | 36,900 | 2,799 | Oct 28, 2010, 05:32 PM |
| Musso Alan A | SVP, CFO & Treasurer | Oct 26, 2010 | Sale | $24.65 | 2,000 | 49,295 | 2,799 | Oct 28, 2010, 05:32 PM |
| Musso Alan A | SVP, CFO & Treasurer | Oct 22, 2010 | Option Exercise | $2.93 | 600 | 1,758 | 3,399 | Oct 26, 2010, 04:44 PM |
| Musso Alan A | SVP, CFO & Treasurer | Oct 25, 2010 | Option Exercise | $2.93 | 8,500 | 24,905 | 11,299 | Oct 26, 2010, 04:44 PM |
| Musso Alan A | SVP, CFO & Treasurer | Oct 22, 2010 | Sale | $24.60 | 600 | 14,760 | 2,799 | Oct 26, 2010, 04:44 PM |
| Musso Alan A | SVP, CFO & Treasurer | Oct 25, 2010 | Sale | $24.69 | 8,500 | 209,892 | 2,799 | Oct 26, 2010, 04:44 PM |
| DUNTON ALAN W | Director | Aug 02, 2010 | Option Exercise | $5.69 | 6,000 | 34,140 | 6,000 | Aug 03, 2010, 08:07 PM |
| DUNTON ALAN W | Director | Aug 02, 2010 | Sale | $22.30 | 6,000 | 133,791 | 0 | Aug 03, 2010, 08:07 PM |
| DUNTON ALAN W | Director | Jul 23, 2010 | Option Exercise | $5.69 | 2,336 | 13,292 | 2,336 | Jul 27, 2010, 07:01 PM |
| DUNTON ALAN W | Director | Jul 26, 2010 | Option Exercise | $5.69 | 2,864 | 16,296 | 2,864 | Jul 27, 2010, 07:01 PM |
| DUNTON ALAN W | Director | Jul 26, 2010 | Sale | $21.12 | 2,864 | 60,476 | 0 | Jul 27, 2010, 07:01 PM |
| DUNTON ALAN W | Director | Jul 23, 2010 | Sale | $21.00 | 2,336 | 49,063 | 0 | Jul 27, 2010, 07:01 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| USMAN NASSIM | President & CEO | 08/09/2022 | 1,527 |
| Miller Seline E. | SVP Finance; Interim CFO & PAO | 08/09/2022 | 1,527 |
| Blouse Grant E. | Chief Scientific Officer | 08/09/2022 | 1,527 |
| USMAN NASSIM | President & CEO | 02/09/2022 | 1,495 |
| Miller Seline E. | SVP Finance; Interim CFO & PAO | 02/09/2022 | 1,495 |
| Blouse Grant E. | Chief Scientific Officer | 02/09/2022 | 1,495 |
| USMAN NASSIM | President & CEO | 08/09/2021 | 3,139 |
| Levy Howard | Chief Medical Officer | 08/09/2021 | 2,313 |
| Blouse Grant E. | Chief Scientific Officer | 08/09/2021 | 4,210 |
| USMAN NASSIM | President & CEO | 04/05/2021 | 23,150 |
| USMAN NASSIM | President & CEO | 02/09/2021 | 2,799 |
| Levy Howard | Chief Medical Officer | 02/09/2021 | 8,033 |
| USMAN NASSIM | President & CEO | 08/10/2020 | 2,799 |
| Levy Howard | Chief Medical Officer | 08/10/2020 | 8,504 |
| Levy Howard | Chief Medical Officer | 03/16/2020 | 10,131 |
| USMAN NASSIM | President & CEO | 03/13/2020 | 15,647 |
| Richard John P | Director | 03/13/2020 | 9,950 |
| Cai Veronica | Controller | 03/13/2020 | 8,220 |
| Williams Eddie | Director | 03/04/2020 | 11,560 |
| Ling Geoffrey M.D. | Director | 02/25/2020 | 18,692 |
| LAWLOR AUGUSTINE | Director | 02/25/2020 | 423,506 |
| USMAN NASSIM | President & CEO | 02/10/2020 | 2,679 |
| Levy Howard | Chief Medical Officer | 02/10/2020 | 8,460 |
| Cai Veronica | Controller | 02/10/2020 | 10,454 |
| Payne Fletcher | Chief Financial Officer | 08/12/2019 | 7,682 |
| USMAN NASSIM | President & CEO | 08/12/2019 | 2,689 |
| Richard John P | Director | 05/24/2019 | 8,030 |
| USMAN NASSIM | President & CEO | 05/21/2019 | 20,372 |
| Levy Howard | Chief Medical Officer | 05/21/2019 | 20,372 |
| Payne Fletcher | Chief Financial Officer | 02/11/2019 | 7,054 |
| USMAN NASSIM | President & CEO | 02/11/2019 | 2,464 |
| Levy Howard | Chief Medical Officer | 02/11/2019 | 17,494 |
| Levy Howard | Chief Medical Officer | 01/31/2019 | 6,945 |
| Payne Fletcher | Chief Financial Officer | 02/04/2019 | 6,959 |
| USMAN NASSIM | President & CEO | 01/31/2019 | 26,525 |
| Levy Howard | Chief Medical Officer | 11/26/2018 | 690 |
| Levy Howard | Chief Medical Officer | 11/16/2018 | 801 |
| Levy Howard | Chief Medical Officer | 11/16/2018 | 1,903 |
| HILL STEPHEN A | Director | 09/06/2018 | 1,913 |
| Levy Howard | Chief Medical Officer | 05/03/2018 | 35,003 |
| USMAN NASSIM | President & CEO | 04/04/2018 | 407 |
| Payne Fletcher | Chief Financial Officer | 03/26/2018 | 273 |
| Flynn James E | 10% Owner | 03/07/2018 | 217,560 |
| Flynn James E | 10% Owner | 03/06/2018 | 445,099 |
| Flynn James E | 10% Owner | 03/06/2018 | 1,174,315 |
| Flynn James E | 10% Owner | 03/08/2018 | 74,664 |
| Flynn James E | 10% Owner | 03/08/2018 | 196,967 |
| Flynn James E | 10% Owner | 03/07/2018 | 82,440 |
| Flynn James E | 10% Owner | 03/08/2018 | 271,631 |
| Flynn James E | 10% Owner | 03/07/2018 | 300,000 |
| Flynn James E | 10% Owner | 03/06/2018 | 1,619,414 |
| USMAN NASSIM | President & CEO | 12/17/2015 | 8,000 |
| Payne Fletcher | Chief Financial Officer | 12/17/2015 | 20,000 |
| HILL STEPHEN A | Director | 12/17/2015 | 10,150 |
| HILL STEPHEN A | Director | 08/28/2015 | 81,621 |
| BARRIS PETER J | 10% Owner | 12/05/2013 | 5,131 |
| SANDELL SCOTT D | 10% Owner | 12/05/2013 | 5,131 |
| BARRETT M JAMES | 10% Owner | 12/03/2013 | 51,525 |
| BARRETT M JAMES | 10% Owner | 12/05/2013 | 5,131 |
| BARRETT M JAMES | 10% Owner | 12/03/2013 | 80,754 |
| BARRIS PETER J | 10% Owner | 11/21/2013 | 27,533 |
| BARRETT M JAMES | 10% Owner | 11/21/2013 | 27,533 |
| SANDELL SCOTT D | 10% Owner | 11/21/2013 | 27,533 |
| BARRIS PETER J | 10% Owner | 06/03/2013 | 75 |
| SANDELL SCOTT D | 10% Owner | 06/03/2013 | 75 |
| BARRETT M JAMES | 10% Owner | 06/03/2013 | 75 |
| BROWN JULIA R | Director | 05/10/2013 | 30,534 |
| HILL STEPHEN A | President and CEO | 03/11/2013 | 43,781 |
| HILL STEPHEN A | President and CEO | 03/08/2013 | 44,796 |
| HILL STEPHEN A | President and CEO | 03/11/2013 | 43,781 |
| HILL STEPHEN A | President and CEO | 03/08/2013 | 44,796 |
| BVF PARTNERS L P/IL | 10% Owner | 11/16/2012 | 2,379,822 |
| BARRIS PETER J | 10% Owner | 11/19/2012 | 250 |
| SANDELL SCOTT D | 10% Owner | 11/19/2012 | 250 |
| KRAMLICH C RICHARD | 10% Owner | 11/19/2012 | 250 |
| BVF PARTNERS L P/IL | 10% Owner | 11/16/2012 | 375,460 |
| BVF PARTNERS L P/IL | 10% Owner | 11/14/2012 | 4,866,848 |
| BVF PARTNERS L P/IL | 10% Owner | 11/08/2012 | 197,651 |
| BVF PARTNERS L P/IL | 10% Owner | 11/07/2012 | 94,276 |
| BVF PARTNERS L P/IL | 10% Owner | 10/31/2012 | 210,896 |
| BVF PARTNERS L P/IL | 10% Owner | 11/02/2012 | 233,482 |
| BVF PARTNERS L P/IL | 10% Owner | 11/01/2012 | 121,800 |
| BURRILL STEVEN | Director | 07/31/2012 | 325 |
| Richard John P | Director | 06/08/2012 | 31,192 |
| Bencherif Merouane | SVP, Preclinical Research | 05/18/2012 | 46,698 |
| deBethizy J Donald | President and CEO | 02/14/2012 | 4,070 |
| Richard John P | Director | 07/01/2011 | 23,175 |
| Richard John P | Director | 07/01/2011 | 52,550 |
| Musso Alan A | SVP, CFO & Treasurer | 06/07/2011 | 166,340 |
| Musso Alan A | SVP, CFO & Treasurer | 06/07/2011 | 672,973 |
| BROWN JULIA R | Director | 05/13/2011 | 79,170 |
| BROWN JULIA R | Director | 05/13/2011 | 212,782 |
| BURRILL STEVEN | Director | 05/10/2011 | 158,803 |
| BURRILL STEVEN | Director | 05/12/2011 | 241,972 |
| BURRILL STEVEN | Director | 05/10/2011 | 48,253 |
| BURRILL STEVEN | Director | 05/10/2011 | 407,471 |
| BURRILL STEVEN | Director | 05/12/2011 | 789,345 |
| BURRILL STEVEN | Director | 05/10/2011 | 158,803 |
| BURRILL STEVEN | Director | 05/11/2011 | 241,972 |
| BURRILL STEVEN | Director | 05/10/2011 | 407,471 |
| BURRILL STEVEN | Director | 05/11/2011 | 789,345 |
| BURRILL STEVEN | Director | 05/10/2011 | 48,253 |
| Richard John P | Director | 04/01/2011 | 23,175 |
| Richard John P | Director | 04/01/2011 | 66,500 |
| Caldwell William S | SVP - Drug Discovery and Dev. | 03/31/2011 | 7,779 |
| Caldwell William S | SVP - Drug Discovery and Dev. | 03/31/2011 | 70,012 |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | 03/09/2011 | 8,325 |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | 03/09/2011 | 45,000 |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | 03/07/2011 | 2,775 |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | 03/03/2011 | 27,917 |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | 03/07/2011 | 15,001 |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | 03/03/2011 | 150,900 |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | 03/01/2011 | 70,502 |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | 03/02/2011 | 1,110 |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | 03/02/2011 | 6,000 |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | 03/01/2011 | 383,144 |
| Brennan Jeffrey P | SVP - Bus. & Commercial Dev. | 03/01/2011 | 3,704 |
| Brennan Jeffrey P | SVP - Bus. & Commercial Dev. | 03/01/2011 | 37,920 |
| Hicks Karen A | VP Human Resources | 03/01/2011 | 10,489 |
| Hicks Karen A | VP Human Resources | 03/01/2011 | 37,290 |
| Caldwell William S | SVP - Drug Discovery and Dev. | 02/28/2011 | 85,920 |
| Caldwell William S | SVP - Drug Discovery and Dev. | 03/01/2011 | 96,674 |
| Caldwell William S | SVP - Drug Discovery and Dev. | 02/28/2011 | 433,468 |
| Caldwell William S | SVP - Drug Discovery and Dev. | 03/01/2011 | 340,800 |
| Caldwell William S | SVP - Drug Discovery and Dev. | 02/16/2011 | 29,146 |
| Caldwell William S | SVP - Drug Discovery and Dev. | 02/16/2011 | 441,656 |
| Richard John P | Director | 01/18/2011 | 6,775 |
| Richard John P | Director | 01/19/2011 | 13,550 |
| Richard John P | Director | 01/18/2011 | 68,440 |
| Richard John P | Director | 01/19/2011 | 135,542 |
| Bencherif Merouane | SVP, Preclinical Research | 01/19/2011 | 83,069 |
| Bencherif Merouane | SVP, Preclinical Research | 01/18/2011 | 126,540 |
| Bencherif Merouane | SVP, Preclinical Research | 01/19/2011 | 818,257 |
| Bencherif Merouane | SVP, Preclinical Research | 01/18/2011 | 619,476 |
| Hicks Karen A | VP Human Resources | 01/14/2011 | 5,037 |
| Hicks Karen A | VP Human Resources | 01/13/2011 | 9,871 |
| Hicks Karen A | VP Human Resources | 01/14/2011 | 47,273 |
| Hicks Karen A | VP Human Resources | 01/13/2011 | 91,760 |
| Hicks Karen A | VP Human Resources | 01/12/2011 | 66,420 |
| Hicks Karen A | VP Human Resources | 01/11/2011 | 86,479 |
| Hicks Karen A | VP Human Resources | 01/11/2011 | 373,571 |
| Hicks Karen A | VP Human Resources | 01/12/2011 | 305,298 |
| Musso Alan A | SVP, CFO & Treasurer | 12/21/2010 | 79,228 |
| Musso Alan A | SVP, CFO & Treasurer | 12/22/2010 | 24,893 |
| Musso Alan A | SVP, CFO & Treasurer | 12/22/2010 | 129,200 |
| Musso Alan A | SVP, CFO & Treasurer | 12/21/2010 | 413,386 |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | 12/20/2010 | 15,544 |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | 12/17/2010 | 3,675 |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | 12/20/2010 | 231,120 |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | 12/17/2010 | 54,765 |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | 12/16/2010 | 22,977 |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | 12/16/2010 | 68,142 |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | 12/16/2010 | 350 |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | 12/16/2010 | 5,030 |
| Caldwell William S | SVP - Drug Discovery and Dev. | 12/13/2010 | 21,000 |
| Caldwell William S | SVP - Drug Discovery and Dev. | 12/13/2010 | 287,377 |
| Brennan Jeffrey P | SVP - Bus. & Commercial Dev. | 12/13/2010 | 29,300 |
| Brennan Jeffrey P | SVP - Bus. & Commercial Dev. | 12/13/2010 | 238,553 |
| Bencherif Merouane | SVP, Preclinical Research | 12/10/2010 | 192,535 |
| Bencherif Merouane | SVP, Preclinical Research | 12/10/2010 | 771,955 |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | 12/08/2010 | 57,375 |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | 12/08/2010 | 255,150 |
| SKALETSKY MARK B | Director | 11/17/2010 | 213,145 |
| SKALETSKY MARK B | Director | 11/16/2010 | 8,130 |
| SKALETSKY MARK B | Director | 11/17/2010 | 649,000 |
| SKALETSKY MARK B | Director | 11/16/2010 | 65,295 |
| BLIXT CHARLES A | Director | 11/16/2010 | 71,790 |
| BLIXT CHARLES A | Director | 11/17/2010 | 50,985 |
| BLIXT CHARLES A | Director | 11/16/2010 | 207,067 |
| BLIXT CHARLES A | Director | 11/17/2010 | 119,666 |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | 11/05/2010 | 1,225 |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | 11/05/2010 | 17,512 |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | 11/05/2010 | 11,914 |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | 11/05/2010 | 35,014 |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | 11/04/2010 | 13,622 |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | 11/03/2010 | 1,726 |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | 11/03/2010 | 24,699 |
| Dunbar Geoffrey C | SVP, Clin. Dev. & Reg. Affairs | 11/04/2010 | 195,139 |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | 11/03/2010 | 8,510 |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | 11/04/2010 | 66,378 |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | 11/04/2010 | 195,605 |
| Hodges Mauri K | VP Fin + Corp Sys & Controller | 11/03/2010 | 25,055 |
| Musso Alan A | SVP, CFO & Treasurer | 10/28/2010 | 4,395 |
| Musso Alan A | SVP, CFO & Treasurer | 10/26/2010 | 5,860 |
| Musso Alan A | SVP, CFO & Treasurer | 10/28/2010 | 36,900 |
| Musso Alan A | SVP, CFO & Treasurer | 10/26/2010 | 49,295 |
| Musso Alan A | SVP, CFO & Treasurer | 10/22/2010 | 1,758 |
| Musso Alan A | SVP, CFO & Treasurer | 10/25/2010 | 24,905 |
| Musso Alan A | SVP, CFO & Treasurer | 10/22/2010 | 14,760 |
| Musso Alan A | SVP, CFO & Treasurer | 10/25/2010 | 209,892 |
| DUNTON ALAN W | Director | 08/02/2010 | 34,140 |
| DUNTON ALAN W | Director | 08/02/2010 | 133,791 |
| DUNTON ALAN W | Director | 07/23/2010 | 13,292 |
| DUNTON ALAN W | Director | 07/26/2010 | 16,296 |
| DUNTON ALAN W | Director | 07/26/2010 | 60,476 |
| DUNTON ALAN W | Director | 07/23/2010 | 49,063 |
Load More Insider Transactions
FUNDS WITH A POSITION IN CATALYST BIOSCIENCES INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 875,886 | 0.00024% | -26.21% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 270,033 | 0.00001% | -1.66% | Other |
| BLACKROCK INC. | 169,904 | 0% | -5.27% | Other |
CHANGE IN SHARES OUTSTANDING FOR CATALYST BIOSCIENCES INC
STOCK BUYBACKS FOR CATALYST BIOSCIENCES INC
Load More
Period of Report: 03/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2022
20.18%
2Q
03/31/2022
20.75%
4Q
09/30/2021
25.02%
6Q
06/30/2021
27.14%
7Q
03/31/2021
33.82%
8Q
Load More